Aim Systematic evidence on the prevalence and clinical outcome of transthyretin
amyloidosis (ATTR) is missing. We explored:(i) the prevalence of cardiac amyloidosis in …

Aims The study aims to systematically assess the diagnostic performance of cardiac
magnetic resonance (CMR) and nuclear scintigraphy (index tests) for the diagnosis and …

Cardiac involvement is the foremost determinant of the clinical progression of amyloidosis.
The diagnostic role of cardiac magnetic resonance (CMR) imaging in cardiac amyloidosis …

Background Advanced cardiac imaging permits optimal targeting of cardiac treatment but
needs to be faster, cheaper, and easier for global delivery. We aimed to pilot rapid cardiac …

Systemic amyloidosis is a serious multiorgan disease with reduced life expectancy,
irrespective of type. The impact of magnetic resonance imaging (MRI) in managing this …

Background: Systemic amyloidosis is a disease with heterogeneous clinical manifestations.
Diagnosis depends on clinical suspicion combined with specific complementary methods …

Cardiac amyloidosis is defined by extracellular deposition of misfolded proteins in the heart.
The most frequent cases of cardiac amyloidosis are caused by transthyretin and light chain …

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative disorder characterized by
extracellular myocardial deposits of amyloid fibrils, with poor outcome, leading to heart …

3 Discussion Senile systemic amyloidosis, caused by wildtype transthyretin (ATTRwt) is
considered as the disease of aged individuals with more severity in octagenerians.[4] …

A substantial increase in the interest in transthyretin cardiac amyloidosis (ATTR-CA) is a
result of the constantly growing number of patients, the use of clear diagnostic protocols and …